PTK2 and neoplasm: As a signal transducer for ECM–tumor cell interactions, FAK1 expression and/or activation has been found altered in most human epithelial cancers, resulting in enhanced invasive potential and poor overall patient survival (McLean et al., 2005; Luo and Guan, 2010).